Principal Financial Group Inc Syros Pharmaceuticals, Inc. Transaction History

Principal Financial Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$3.26 - $4.66 $39,899 - $57,033	-12,239 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$4.08 - $5.66 $8,106 - $11,246	-1,987 Reduced 13.97%	12,239 $55,000
Q2 2021 Aug 10, 2021	BUY	$5.01 - $7.48 $20,856 - $31,139	4,163 Added 41.37%	14,226 $77,000
Q1 2021 May 10, 2021	SELL	$7.19 - $14.95 $3,235 - $6,727	-450 Reduced 4.28%	10,063 $75,000
Q4 2020 Feb 08, 2021	BUY	$6.66 - $14.66 $70,016 - $154,120	10,513 New	10,513 $114,000

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $43.1M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.